Cytochrome P450 1A1/2, 2B6 and 3A4 HepaRG Cell-Based Biosensors to Monitor Hepatocyte Differentiation, Drug Metabolism and Toxicity

Human hepatoma HepaRG cells express most drug metabolizing enzymes and constitute a pertinent in vitro alternative cell system to primary cultures of human hepatocytes in order to determine drug metabolism and evaluate the toxicity of xenobiotics. In this work, we established novel transgenic HepaRG cells transduced with lentiviruses encoding the reporter green fluorescent protein (GFP) transcriptionally regulated by promoter sequences of cytochromes P450 (CYP) 1A1/2, 2B6 and 3A4 genes. Here, we demonstrated that GFP-biosensor transgenes shared similar expression patterns with the corresponding endogenous CYP genes during proliferation and differentiation in HepaRG cells. Interestingly, differentiated hepatocyte-like HepaRG cells expressed GFP at higher levels than cholangiocyte-like cells. Despite weaker inductions of GFP expression compared to the strong increases in mRNA levels of endogenous genes, we also demonstrated that the biosensor transgenes were induced by prototypical drug inducers benzo(a)pyrene and phenobarbital. In addition, we used the differentiated biosensor HepaRG cells to evidence that pesticide mancozeb triggered selective cytotoxicity of hepatocyte-like cells. Our data demonstrate that these new biosensor HepaRG cells have potential applications in the field of chemicals safety evaluation and the assessment of drug hepatotoxicity.

[1]  S. Langouet,et al.  Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  W. Suter Predictive value of in vitro safety studies. , 2006, Current opinion in chemical biology.

[3]  J. Pascussi,et al.  Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes. , 2011, Environmental toxicology and pharmacology.

[4]  A. Guillouzo,et al.  Optimization of the HepaRG cell model for drug metabolism and toxicity studies. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  R. Rose,et al.  Endosulfan‐α Induces CYP2B6 and CYP3A4 by Activating the Pregnane X Receptor , 2010, Toxicology and applied pharmacology.

[6]  B. Drénou,et al.  Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor , 2007, Hepatology.

[7]  C. Guguen-Guillouzo,et al.  Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye. , 2011, Toxicology and applied pharmacology.

[8]  Olivier Fardel,et al.  Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  S. Wolfe,et al.  Timing of new black box warnings and withdrawals for prescription medications. , 2002, JAMA.

[10]  D. Lagadic-Gossmann,et al.  Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation* , 2002, The Journal of Biological Chemistry.

[11]  P. Staňková,et al.  The toxic effect of thioacetamide on rat liver in vitro. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  André Guillouzo,et al.  EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS , 2006, Drug Metabolism and Disposition.

[13]  Frank Stahl,et al.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[14]  Tsuneo Hashizume,et al.  Advantages of human hepatocyte-derived transformants expressing a series of human cytochrome p450 isoforms for genotoxicity examination. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  K. Boudjema,et al.  Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression. , 2009, European journal of cancer.

[16]  D. Zalko,et al.  Use of the γH2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. , 2010, Toxicology letters.

[17]  D. Glaise,et al.  Inflammatory cytokines promote the retrodifferentiation of tumor‐derived hepatocyte‐like cells to progenitor cells , 2014, Hepatology.

[18]  A. Guillouzo,et al.  Interindividual Variability in Gene Expression Profiles in Human Hepatocytes and Comparison with HepaRG Cells , 2012, Drug Metabolism and Disposition.

[19]  M. Filipič,et al.  A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents. , 2014, Biosensors & bioelectronics.

[20]  L. Corcos,et al.  Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. , 1993, Molecular pharmacology.

[21]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Corcos,et al.  Up-regulation of glutathione S-transferases alpha by interleukin 4 in human hepatocytes in primary culture. , 1995, Biochemical and biophysical research communications.

[23]  M. Vinken,et al.  Characterization of hepatocyte-based in vitro systems for reliable toxicity testing , 2018, Archives of Toxicology.

[24]  J. Castell,et al.  Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .

[25]  A. Guillouzo,et al.  Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines. , 2010, Toxicology and applied pharmacology.

[26]  Mitsuo Oshimura,et al.  Dual-Color Fluorescence Imaging to Monitor CYP3A4 and CYP3A7 Expression in Human Hepatic Carcinoma HepG2 and HepaRG Cells , 2014, PloS one.

[27]  A. Puisieux,et al.  Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[28]  Marlon J. A. Jetten,et al.  Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  M. Lamberti,et al.  Mancozeb, a fungicide routinely used in agriculture, worsens nonalcoholic fatty liver disease in the human HepG2 cell model. , 2016, Toxicology letters.

[30]  P. Loyer,et al.  Efficient transfection of Xenobiotic Responsive Element-biosensor plasmid using diether lipid and phosphatidylcholine liposomes in differentiated HepaRG cells. , 2017, International journal of pharmaceutics.

[31]  G. Hatch,et al.  Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells. , 2016, Biochimica et biophysica acta.

[32]  R. Hanzlik,et al.  Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes. , 2012, Chemical research in toxicology.

[33]  Valérie Fessard,et al.  Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies , 2008, Drug Metabolism and Disposition.

[34]  P. Loyer,et al.  Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes , 2018, Archives of Toxicology.

[35]  P. Loyer,et al.  Evaluation of genotoxicity using automated detection of γH2AX in metabolically competent HepaRG cells. , 2015, Mutagenesis.

[36]  Tommy B Andersson,et al.  Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies , 2008, Drug Metabolism and Disposition.

[37]  André Guillouzo,et al.  Evolving concepts in liver tissue modeling and implications for in vitro toxicology , 2008, Expert opinion on drug metabolism & toxicology.